Deep Brain Stimulation of the Anterior Nucleus of the Thalamus in Epilepsy (FRANCE)
Clinical and Medico-economical Assessment of Deep Brain Stimulation of the Anterior Nucleus of the Thalamus for the Treatment of Pharmacoresistant Partial Epilepsy
Sponsor: University Hospital, Grenoble
Listed as NCT02076698, this PHASE3 trial focuses on Partial Epilepsy and Surgery and remains completed. Sponsored by University Hospital, Grenoble, it has been updated 8 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Apr 2022 — Jul 2024 [monthly]
Completed PHASE3
Status: Active Not Recruiting → Completed
-
Jan 2021 — Apr 2022 [monthly]
Active Not Recruiting PHASE3
-
Dec 2020 — Jan 2021 [monthly]
Active Not Recruiting PHASE3
▶ Show 3 earlier versions
-
Apr 2020 — Dec 2020 [monthly]
Active Not Recruiting PHASE3
Status: Recruiting → Active Not Recruiting
-
Jun 2018 — Apr 2020 [monthly]
Recruiting PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Recruiting PHASE3
First recorded
Jun 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University Hospital, Grenoble
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Bordeaux, France , Grenoble, France , Lille, France , Lyon, France , Marseille, France , Montpellier, France , Nancy, France , Nice, France , Paris, France , Rennes, France and 1 more location